BRIEF-MabVax Therapeutics Holdings announces pricing of registered direct offering
Aug 14 (Reuters) - MabVax Therapeutics Holdings Inc
* MabVax Therapeutics Holdings Inc announces pricing of registered direct offering
* MabVax Therapeutics - ‍purchase agreements with investors providing for registered sale of about $1.3 million of shares of Series J convertible preferred stock​
* MabVax Therapeutics Holdings Inc - ‍registered direct offering represents about 2,386.36 shares at a purchase price of $550 per share​ Source text for Eikon: Further company coverage: